Detalles de la búsqueda
1.
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease.
Eur J Clin Pharmacol
; 79(9): 1219-1228, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37436495
Resultados
1 -
1
de 1
1
Próxima >
>>